Back to Search Start Over

Singlet Oxygen in Photodynamic Therapy.

Authors :
Cui S
Guo X
Wang S
Wei Z
Huang D
Zhang X
Zhu TC
Huang Z
Source :
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2024 Sep 26; Vol. 17 (10). Date of Electronic Publication: 2024 Sep 26.
Publication Year :
2024

Abstract

Photodynamic therapy (PDT) is a therapeutic modality that depends on the interaction of light, photosensitizers, and oxygen. The photon absorption and energy transfer process can lead to the Type II photochemical reaction of the photosensitizer and the production of singlet oxygen ( <superscript>1</superscript> O <subscript>2</subscript> ), which strongly oxidizes and reacts with biomolecules, ultimately causing oxidative damage to the target cells. Therefore, <superscript>1</superscript> O <subscript>2</subscript> is regarded as the key photocytotoxic species accountable for the initial photodynamic reactions for Type II photosensitizers. This article will provide a comprehensive review of <superscript>1</superscript> O <subscript>2</subscript> properties, <superscript>1</superscript> O <subscript>2</subscript> production, and <superscript>1</superscript> O <subscript>2</subscript> detection in the PDT process. The available <superscript>1</superscript> O <subscript>2</subscript> data of regulatory-approved photosensitizing drugs will also be discussed.

Details

Language :
English
ISSN :
1424-8247
Volume :
17
Issue :
10
Database :
MEDLINE
Journal :
Pharmaceuticals (Basel, Switzerland)
Publication Type :
Academic Journal
Accession number :
39458915
Full Text :
https://doi.org/10.3390/ph17101274